Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traits

Journal of Hepatology

Volumn 60, Issue 2, 2014, Pages 346-353

  Marquardt, Jens U ^a,b   Seo, Daekwan ^a   Andersen, Jesper B ^a   Gillen, Matthew C ^a   Kim, Myoung Soo ^c   Conner, Elizabeth A ^a   Galle, Peter R ^b   Factor, Valentina M ^a   Park, Young Nyun ^c   Thorgeirsson, Snorri S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Hepatocarcinogenesis; Molecular pathogenesis; RNA sequencing

Indexed keywords

NOTCH RECEPTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EARLY CANCER; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC ANALYSIS; GENETIC VARIABILITY; HEPATITIS B; HEREDITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MALIGNANT TRANSFORMATION; MIDDLE AGED; PRIORITY JOURNAL; PROGNOSIS; RNA SEQUENCE; SEQUENCE ANALYSIS; TRANSCRIPTOMICS; TUMOR GENE;

ADULT; AGED; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, NEOPLASM; TUMOR MICROENVIRONMENT;

EID: 84892548240     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.10.014     Document Type: Article

References (46)

1. M. Kojiro, and T. Roskams Early hepatocellular carcinoma and dysplastic nodules Semin Liver Dis 25 2005 133 142
2. Pathologic diagnosis of early hepatocellular carcinoma A report of the international consensus group for hepatocellular neoplasia Hepatology 49 2009 658 664
3. T. Aihara, S. Noguchi, Y. Sasaki, H. Nakano, M. Monden, and S. Imaoka Clonal analysis of precancerous lesion of hepatocellular carcinoma Gastroenterology 111 1996 455 461
4. European Association For The Study Of The L, European Organisation For R, Treatment Of C EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
5. J.M. Llovet, A.M. Di Bisceglie, J. Bruix, B.S. Kramer, R. Lencioni, and A.X. Zhu et al. Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
6. B. Langmead, C. Trapnell, M. Pop, and S.L. Salzberg Ultrafast and memory-efficient alignment of short DNA sequences to the human genome Genome Biol 10 2009 R25
7. H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, and N. Homer et al. The sequence alignment/map format and SAM tools Bioinformatics 25 2009 2078 2079
8. A. Mortazavi, B.A. Williams, K. McCue, L. Schaeffer, and B. Wold Mapping and quantifying mammalian transcriptomes by RNA-Seq Nat Methods 5 2008 621 628
9. L. Wang, Z. Feng, X. Wang, X. Wang, and X. Zhang DEGseq: an R package for identifying differentially expressed genes from RNA-seq data Bioinformatics 26 2010 136 138
10. D.C. Koboldt, K. Chen, T. Wylie, D.E. Larson, M.D. McLellan, and E.R. Mardis et al. VarScan: variant detection in massively parallel sequencing of individual and pooled samples Bioinformatics 25 2009 2283 2285
11. K. Wang, M. Li, and H. Hakonarson ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data Nucleic Acids Res 38 2010 e164
12. J.U. Marquardt, P.R. Galle, and A. Teufel Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies J Hepatol 56 2012 267 275
13. D. Alfano, G. Votta, A. Schulze, J. Downward, M. Caputi, and M.P. Stoppelli et al. Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor Mol Cell Biol 30 2010 1838 1851
14. S.R. Alonso, L. Tracey, P. Ortiz, B. Perez-Gomez, J. Palacios, and M. Pollan et al. A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis Cancer Res 67 2007 3450 3460
15. D.Y. Chiang, A. Villanueva, Y. Hoshida, J. Peix, P. Newell, and B. Minguez et al. Focal gains of VEGFA and molecular classification of hepatocellular carcinoma Cancer Res 68 2008 6779 6788
16. C. Coulouarn, V.M. Factor, and S.S. Thorgeirsson Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer Hepatology 47 2008 2059 2067
17. Y. Hoshida, S.M. Nijman, M. Kobayashi, J.A. Chan, J.P. Brunet, and D.Y. Chiang et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma Cancer Res 69 2009 7385 7392
18. J.S. Lee, J. Heo, L. Libbrecht, I.S. Chu, P. Kaposi-Novak, and D.F. Calvisi et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells NatMed 12 2006 410 416
19. B.C. Nguyen, K. Lefort, A. Mandinova, D. Antonini, and V. Devgan Della Gatta G, et al. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation Genes Dev 20 2006 1028 1042
20. S. Rutella, G. Bonanno, A. Procoli, A. Mariotti, D.G. de Ritis, and A. Curti et al. Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features Blood 108 2006 218 227
21. C.F. Schaefer, K. Anthony, S. Krupa, J. Buchoff, M. Day, and T. Hannay et al. PID: the pathway interaction database Nucleic Acids Res 37 2009 D674 D679
22. J.B. Andersen, V.M. Factor, J.U. Marquardt, C. Raggi, Y.H. Lee, and D. Seo et al. An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer Sci Transl Med 2 2010 54ra77
23. C. Guichard, G. Amaddeo, S. Imbeaud, Y. Ladeiro, L. Pelletier, and I.B. Maad et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma Nat Genet 44 2012 694 698
24. A. Fujimoto, Y. Totoki, T. Abe, K.A. Boroevich, F. Hosoda, and H.H. Nguyen et al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators Nat Genet 44 2012 760 764
25. P. Kaposi-Novak, L. Libbrecht, H.G. Woo, Y.H. Lee, N.C. Sears, and E.A. Conner et al. Central role of c-Myc during malignant conversion in human hepatocarcinogenesis Cancer Res 69 2009 2775 2782
26. S.S. Thorgeirsson The almighty MYC: orchestrating the micro-RNA universe to generate aggressive liver cancer J Hepatol 55 2011 486 487
27. V.W. Keng, D. Sia, A.L. Sarver, B.R. Tschida, D. Fan, and C. Alsinet et al. Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR Hepatology 57 2013 120 130
28. Z. Li, G. Tuteja, J. Schug, and K.H. Kaestner Foxa1 and Foxa2 are essential for sexual dimorphism in liver cancer Cell 148 2012 72 83
29. M. Roncalli, Y.N. Park, and L. Di Tommaso Histopathological classification of hepatocellular carcinoma Dig Liver Dis 42 2010 S228 S234
30. T.Y. Chen, Y.C. Li, Y.F. Liu, C.M. Tsai, Y.H. Hsieh, and C.W. Lin et al. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma Ann Surg Oncol 18 2011 2348 2356
31. R. Li, Y. Yang, Y. An, Y. Zhou, Y. Liu, and Q. Yu et al. Genetic polymorphisms in DNA double-strand break repair genes XRCC5, XRCC6 and susceptibility to hepatocellular carcinoma Carcinogenesis 32 2011 530 536
32. J.H. Luo, B. Ren, S. Keryanov, G.C. Tseng, U.N. Rao, and S.P. Monga et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas Hepatology 44 2006 1012 1024
33. K. Migita, S. Miyazoe, Y. Maeda, M. Daikoku, S. Abiru, and T. Ueki et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma J Hepatol 42 2005 505 510
34. Y. Pei, J. Kano, T. Iijima, Y. Morishita, Y. Inadome, and M. Noguchi Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas Virchows Arch 454 2009 639 646
35. A. Umemura, Y. Itoh, K. Itoh, K. Yamaguchi, T. Nakajima, and H. Higashitsuji et al. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma Hepatology 47 2008 493 502
36. A. Villanueva, P. Newell, D.Y. Chiang, S.L. Friedman, and J.M. Llovet Genomics and signaling pathways in hepatocellular carcinoma Semin Liver Dis 27 2007 55 76
37. H.J. Xie, H.J. Bae, J.H. Noh, J.W. Eun, J.K. Kim, and K.H. Jung et al. Mutational analysis of JAK1 gene in human hepatocellular carcinoma Neoplasma 56 2009 136 140
38. H.G. Woo, E.S. Park, J.S. Lee, Y.H. Lee, T. Ishikawa, and Y.J. Kim et al. Identification of potential driver genes in human liver carcinoma by genomewide screening Cancer Res 69 2009 4059 4066
39. L. Chen, Y. Li, C.H. Lin, T.H. Chan, R.K. Chow, and Y. Song et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma Nat Med 19 2013 209 216
40. J.C. Nault, M. Mallet, C. Pilati, J. Calderaro, P. Bioulac-Sage, and C. Laurent et al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions Nat Commun 4 2013
41. O. Neumann, M. Kesselmeier, R. Geffers, R. Pellegrino, B. Radlwimmer, and K. Hoffmann et al. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors Hepatology 56 2012 1817 1827
42. S. Boudoukha, S. Cuvellier, and A. Polesskaya Role of the RNA-binding protein IMP-2 in muscle cell motility Mol Cell Biol 30 2010 5710 5725
43. D. Kuninger, R. Kuzmickas, B. Peng, J.E. Pintar, and P. Rotwein Gene discovery by microarray: identification of novel genes induced during growth factor-mediated muscle cell survival and differentiation Genomics 84 2004 876 889
44. E. Wurmbach, Y.B. Chen, G. Khitrov, W. Zhang, S. Roayaie, and M. Schwartz et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma Hepatology 45 2007 938 947
45. S. Roessler, H.L. Jia, A. Budhu, M. Forgues, Q.H. Ye, and J.S. Lee et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients Cancer Res 70 2010 10202 10212
46. V.R. Mas, D.G. Maluf, K.J. Archer, K. Yanek, X. Kong, and L. Kulik et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma Mol Med 15 2009 85 94